NCT04699097View on ClinicalTrials.gov

The Effect of Azithromycin Use on Conduction System of Heart in COVID-19 Positive Children

CompletedOBSERVATIONAL
Enrollment

105

Participants

Timeline

Start Date

July 1, 2020

Primary Completion Date

September 1, 2020

Study Completion Date

November 1, 2020

Conditions
Azithromycin Adverse ReactionCovid19Long QT Syndrome
Interventions
DRUG

Azithromycin

250 mg tablet, 5 ml / 200 mg 30 ml suspension

Trial Locations (1)

(554) 217-68

Süleyman Sunkak, Kayseri

All Listed Sponsors
lead

Kayseri City Hospital

OTHER_GOV

NCT04699097 - The Effect of Azithromycin Use on Conduction System of Heart in COVID-19 Positive Children | Biotech Hunter | Biotech Hunter